期刊
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
卷 17, 期 3-4, 页码 217-228出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10911-012-9265-1
关键词
Apoptosis; IAPs; Smac; Small-molecule drugs
资金
- Breast Cancer Research Foundation
- Prostate Cancer Foundation
- Department of Defense Prostate Cancer Program [W81XWH-04-1-0213]
- Ascenta Therapeutics
- National Cancer Institute, NIH [5R01CA109025, 5R01CA127551]
Apoptosis resistance is a hallmark of human cancer. Research in the last two decades has identified key regulators of apoptosis, including inhibitor of apoptosis proteins (IAPs). These critical apoptosis regulators have been targeted for the development of new cancer therapeutics. In this article, we will discuss three members of IAP proteins, namely XIAP, cIAP1 and cIAP2, as cancer therapeutic targets and the progress made in developing new cancer therapeutic agents to target these IAP proteins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据